Latest Updates
-
Ganesh Chaturthi 2026: Inside The Star-Studded Celebrations At Lalbaugcha Raja And Antilia -
The 5-Minute Childhood Skincare Routine: Why Simpler May Actually Be Better -
OTT Releases This Week (September 14–20): What To Watch Across Netflix, Prime Video, JioHotstar And More -
Fiji's HIV Cases Have Risen 16-Fold Since 2019 — Now It's A National Emergency -
Can a 50-Year-Old Develop Alzheimer's? What Early-Onset Dementia Looks Like -
Mahalaxmi Vrat 2026: Date, Puja Vidhi, And The Legend Behind The 16 Knots -
Who Is Anant Nag? Meet The Veteran Kannada Actor Set To Receive Dadasaheb Phalke Award -
Monsoon And Diabetes: Why Infection Risk Increases During The Rainy Season -
Throwback Thursday: Kareena Kapoor’s ‘Poo’ To Priyanka Chopra’s ‘Desi Girl’, Bollywood Looks That Ruled 2000s -
PM Narendra Modi Birthday Special: Make His Favourite Khichdi At Home And Know Its Health Benefits
Childhood Cancer Treatment May Affect Short-Term Memory
Children exposed to cancer treatment such as chemotherapy are likely to have decreased cognitive flexibility and a weaker short-term memory, researchers say.
Children exposed to cancer treatment such as chemotherapy are likely to have decreased cognitive flexibility and a weaker short-term memory, researchers say.
The results show that cognitive functions which are slow developing or mature during adolescence -- in particular short-term memory -- are very vulnerable to the chemotherapy treatment.

However, cognitive functions such as long-term memory and the ability to concentrate remain largely unaffected as they develop before the treatment.
"Tests that require quick switching between tasks or remembering new information for a short amount of time were clearly more difficult for former cancer patients. The developmental stage of the brain at the start of the cancer treatment probably plays a decisive role," Rudi D'Hooge, Professor at the University of Leuven in Belgium.
For the study, the team examined 31 young adults who underwent chemotherapy as a child, on average around the age of six and a half.
The survivors' performance was compared on a number of psychological tests with the results of a control group.
Further, analysing phosphorylated Tau (p-Tau) -- a protein which is part of the internal structure of our nerve cells -- the researchers found that high concentrations of p-Tau predict cognitive problems at a later age.

"If we systematically measure these p-Tau levels in the future, we can offer specific help to children with high values. With early coaching aimed at the most relevant functions we can prevent problems that would otherwise manifest 10 to 15 years after the treatment," Iris Elens, a psychiatrist at the University of Leuven.
With Inputs From IANS
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
